INOVIO PHARMACEUTICALS, INC. Common Stock, Value, Issued
INOVIO PHARMACEUTICALS, INC. (INO) had Common Stock, Value, Issued of $82.34 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-12
- 2026-06-30: Common Stock, Value, Issued $82.34K.
- 2026-03-31: Common Stock, Value, Issued $69.77K.
- 2025-12-31: Common Stock, Value, Issued $69.00K.
- 2025-09-30: Common Stock, Value, Issued $53.57K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $82.34K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $69.77K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $69.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $53.57K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $36.72K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $36.67K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $36.10K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $26.05K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $25.96K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $23.37K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $22.79K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $269.73K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $268.07K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $262.74K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $21.09K 10-K · filed 2024-03-06 | $253.09K 10-K · filed 2023-03-01 |
| 2022-09-30 | $249.48K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $247.50K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $226.51K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $217.38K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $210.36K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $210.15K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $209.33K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $186.85K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $167.53K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $158.76K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $145.91K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $101.36K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $99.05K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $98.58K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $97.93K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $97.23K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $94.47K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $91.47K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $90.70K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $90.36K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $90.30K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $77.63K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $74.63K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $74.06K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $73.97K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $73.48K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $72.27K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $72.22K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $72.18K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $71.81K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $60.74K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $60.74K 10-K · filed 2016-03-14 | |
| 2014-09-30 | $60.46K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $60.32K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $240.15K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $52.58K 10-K · filed 2015-03-16 | $210.31K 10-K · filed 2014-03-17 |
| 2013-09-30 | $207.62K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $180.06K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $179.94K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $144.31K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $137.06K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $134.97K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $134.97K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $134.97K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $127.26K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $127.26K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $105.04K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |